Skip to main content
SpringerLink
Log in

Invasive Electrophysiologic Testing: Role in Sudden Death Prediction

  • Chapter
  • First Online:
Electrical Diseases of the Heart

  • 2098 Accesses

Abstract

Programmed ventricular stimulation has dramatically advanced understanding of ventricular tachycardia after myocardial infarction. It remains an important tool for sudden cardiac death risk assessment in certain groups of patients. Its role in patients without infarct-related scar is less clear. Current role of programmed ventricular stimulation, invasive assessment of accessory pathway properties and HV interval measurement is discussed in detail.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    The induction of polymorphic VT with 3 extrastimuli counted as positive result, though VF still had to be induced with 1 or 2 extrastimuli to count as a positive result.

Abbreviations

AAD:

Antiarrhythmic drugs

ARVD:

Arrhythmogenic right ventricular dysplasia

AV:

Atrioventricular

CAD:

Coronary artery disease

CASCADE:

Cardiac Arrest in Seattle: Conventional Versus Amiodarone Drug Evaluation

CAST:

Cardiac Arrhythmia Suppression Trial

CAST-II:

Cardiac Arrhythmia Suppression Trial II

CL:

Cycle length

DCM:

Dilated cardiomyopathy

ERP:

Effective refractory period

ESVEM:

Electrophysiologic Study versus Electrocardiographic Monitoring Trial

HCM:

Hypertrophic cardiomyopathy

ICD:

Implantable cardioverter defibrillator

LV:

Left ventricle left ventricular

LVEF:

Left ventricular ejection fraction

MADIT:

Multicenter Automatic Defibrillator Implantation Trial

MADIT-2:

Multicenter Automatic Defibrillator Implantation Trial II

MI:

Myocardial infarction

MUSTT:

Multicenter Unsustained Tachycardia Trial

PVS:

Programmed ventricular stimulation

RFA:

Radiofrequency ablation

RV:

Right ventricle, or right ventricular

RVA:

Right ventricular apex

RVOT:

Right ventricular outflow tract

SCD:

Sudden cardiac death

SMVT:

Sustained monomorphic ventricular tachycardia

TOF:

Tetralogy of Fallot

VF:

Ventricular fibrillation

VT:

Ventricular tachycardia

WPW:

Wolff-Parkinson-White

References

  1. Wellens HJ, Schuilenburg RM, Durrer D. Electrical stimulation of the heart in patients with ventricular tachycardia. Circulation. 1972;46:216–26.

    Article  PubMed  CAS  Google Scholar 

  2. Lin HT, Mann DE, Luck JC, Krafchek J, Magro SA, Sakun V, et al. Prospective comparison of right and left ventricular stimulation for induction of sustained ventricular tachycardia. Am J Cardiol. 1987;59:559–63.

    Article  PubMed  CAS  Google Scholar 

  3. Michelson EL, Spielman SR, Greenspan AM, Farshidi A, Horowitz LN, Josephson ME. Electrophysiologic study of the left ventricle: indications and safety. Chest. 1979;75:592–6.

    Article  PubMed  CAS  Google Scholar 

  4. Buxton AE, Fisher JD, Josephson ME, Lee KL, Pryor DB, Prystowsky EN, et al. Prevention of sudden death in patients with coronary artery disease: the multicenter unsustained tachycardia trial (MUSTT). Prog Cardiovasc Dis. 1993;36:215–26.

    Article  PubMed  CAS  Google Scholar 

  5. Hummel JD, Strickberger SA, Daoud E, Niebauer M, Bakr O, Man KC, et al. Results and efficiency of programmed ventricular stimulation with four extrastimuli compared with one, two, and three extrastimuli. Circulation. 1994;90:2827–32.

    Article  PubMed  CAS  Google Scholar 

  6. Denker S, Lehmann MH, Mahmud R, Gilbert C, Akhtar M. Facilitation of macroreentry within the His-Purkinje system with abrupt changes in cycle length. Circulation. 1984;69:26–32.

    Article  PubMed  CAS  Google Scholar 

  7. Niebauer M, Daoud E, Goyal R, Chan KK, Harvey M, Bogun F, et al. Use of isoproterenol during programmed ventricular stimulation in patients with coronary artery disease and nonsustained ventricular tachycardia. Am Heart J. 1996;131:516–8.

    Article  PubMed  CAS  Google Scholar 

  8. Morady F, DiCarlo L, Winston S, Davis JC, Scheinman MM. A prospective comparison of triple extrastimuli and left ventricular stimulation in studies of ventricular tachycardia induction. Circulation. 1984;70:52–7.

    Article  PubMed  CAS  Google Scholar 

  9. Morady F, DiCarlo Jr LA, Baerman JM, de Buitleir M. Comparison of coupling intervals that induce clinical and nonclinical forms of ventricular tachycardia during programmed stimulation. Am J Cardiol. 1986;57:1269–73.

    Article  PubMed  CAS  Google Scholar 

  10. Brugada P, Wellens HJ. Comparison in the same patient of two programmed ventricular stimulation protocols to induce ventricular tachycardia. Am J Cardiol. 1985;55:380–3.

    Article  PubMed  CAS  Google Scholar 

  11. Kennedy EE, Rosenfeld LE, McPherson CA, Stark SI, Batsford WP. Mechanisms and relevance of arrhythmias induced by high-current programmed ventricular stimulation. Am J Cardiol. 1986;57:598–603.

    Article  PubMed  CAS  Google Scholar 

  12. Weissberg PL, Broughton A, Harper RW, Young A, Pitt A. Induction of ventricular arrhythmias by programmed ventricular stimulation: a prospective study on the effects of stimulation current on arrhythmia induction. Br Heart J. 1987;58:489–94.

    Article  PubMed  CAS  Google Scholar 

  13. de Buitleir M, Morady F, DiCarlo Jr LA, Baerman JM, Krol RB. Immediate reproducibility of clinical and nonclinical forms of induced ventricular tachycardia. Am J Cardiol. 1986;58:279–82.

    Article  PubMed  Google Scholar 

  14. Lombardi F, Stein J, Podrid PJ, Graboys TB, Lown B. Daily reproducibility of electrophysiologic test results in malignant ventricular arrhythmia. Am J Cardiol. 1986;57:96–101.

    Article  PubMed  CAS  Google Scholar 

  15. McPherson CA, Rosenfeld LE, Batsford WP. Day-to-day reproducibility of responses to right ventricular programmed electrical stimulation: implications for serial drug testing. Am J Cardiol. 1985;55:689–95.

    Article  PubMed  CAS  Google Scholar 

  16. Rosenbaum MS, Wilber DJ, Finkelstein D, Ruskin JN, Garan H. Immediate reproducibility of electrically induced sustained monomorphic ventricular tachycardia before and during antiarrhythmic therapy. J Am Coll Cardiol. 1991;17:133–8.

    Article  PubMed  CAS  Google Scholar 

  17. Wilber DJ, Garan H, Finkelstein D, Kelly E, Newell J, McGovern B, et al. Out-of-hospital cardiac arrest. Use of electrophysiologic testing in the prediction of long-term outcome. N Engl J Med. 1988;318:19–24.

    Article  PubMed  CAS  Google Scholar 

  18. Steinbeck G, Andresen D, Bach P, Haberl R, Oeff M, Hoffmann E, et al. A comparison of electrophysiologically guided antiarrhythmic drug therapy with beta-blocker therapy in patients with symptomatic, sustained ventricular tachyarrhythmias. N Engl J Med. 1992;327:987–92.

    Article  PubMed  CAS  Google Scholar 

  19. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter unsustained tachycardia trial investigators. N Engl J Med. 1999;341:1882–90.

    Article  PubMed  CAS  Google Scholar 

  20. Buxton AE, Lee KL, DiCarlo L, Gold MR, Greer GS, Prystowsky EN, et al. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter unsustained tachycardia trial investigators. N Engl J Med. 2000;342:1937–45.

    Article  PubMed  CAS  Google Scholar 

  21. Daubert JP, Zareba W, Hall WJ, Schuger C, Corsello A, Leon AR, et al. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients. J Am Coll Cardiol. 2006;47:98–107.

    Article  PubMed  Google Scholar 

  22. Bhandari AK, Widerhorn J, Sager PT, Leon C, Hong R, Kotlewski A, et al. Prognostic significance of programmed ventricular stimulation in patients surviving complicated acute myocardial infarction: a prospective study. Am Heart J. 1992;124:87–96.

    Article  PubMed  CAS  Google Scholar 

  23. Bourke JP, Young AA, Richards DA, Uther JB. Reduction in incidence of inducible ventricular tachycardia after myocardial infarction by treatment with streptokinase during infarct evolution. J Am Coll Cardiol. 1990;16:1703–10.

    Article  PubMed  CAS  Google Scholar 

  24. Mittal S, Hao SC, Iwai S, Stein KM, Markowitz SM, Slotwiner DJ, et al. Significance of inducible ventricular fibrillation in patients with coronary artery disease and unexplained syncope. J Am Coll Cardiol. 2001;38:371–6.

    Article  PubMed  CAS  Google Scholar 

  25. Link MS, Saeed M, Gupta N, Homoud MK, Wang PJ, Estes III NA. Inducible ventricular flutter and fibrillation predict for arrhythmia occurrence in coronary artery disease patients presenting with syncope of unknown origin. J Cardiovasc Electrophysiol. 2002;13:1103–8.

    Article  PubMed  Google Scholar 

  26. Epstein AE, DiMarco JP, Ellenbogen KA, Estes 3rd NA, Freedman RA, Gettes LS, et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation. 2008;117:e350–408.

    Article  PubMed  Google Scholar 

  27. Kumar S, Sivagangabalan G, Choi MC, Eipper V, Thiagalingam A, Kovoor P. Long-term outcomes of inducible very fast ventricular tachycardia (cycle length 200–250 ms) in patients with ischemic cardiomyopathy. J Cardiovasc Electrophysiol. 2010;21:262–9.

    Article  PubMed  Google Scholar 

  28. Viskin S, Ish-Shalom M, Koifman E, Rozovski U, Zeltser D, Glick A, et al. Ventricular flutter induced during electrophysiologic studies in patients with old myocardial infarction: clinical and electrophysiologic predictors, and prognostic significance. J Cardiovasc Electrophysiol. 2003;14:913–9.

    Article  PubMed  Google Scholar 

  29. Richards DA, Cody DV, Denniss AR, Russell PA, Young AA, Uther JB. Ventricular electrical instability: a predictor of death after myocardial infarction. Am J Cardiol. 1983;51:75–80.

    Article  PubMed  CAS  Google Scholar 

  30. Bhandari AK, Au PK, Rose JS, Kotlewski A, Blue S, Rahimtoola SH. Decline in inducibility of sustained ventricular tachycardia from two to twenty weeks after acute myocardial infarction. Am J Cardiol. 1987;59:284–90.

    Article  PubMed  CAS  Google Scholar 

  31. Nogami A, Aonuma K, Takahashi A, Nitta J, Chun YH, Iesaka Y, et al. Usefulness of early versus late programmed ventricular stimulation in acute myocardial infarction. Am J Cardiol. 1991;68:13–20.

    Article  PubMed  CAS  Google Scholar 

  32. Kumar S, Sivagangabalan G, Zaman S, West EB, Narayan A, Thiagalingam A, et al. Electrophysiology-guided defibrillator implantation early after ST-elevation myocardial infarction. Heart Rhythm. 2010;7:1589–97.

    Article  PubMed  Google Scholar 

  33. Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R, et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med. 2004;351:2481–8.

    Article  PubMed  CAS  Google Scholar 

  34. Steinbeck G, Andresen D, Seidl K, Brachmann J, Hoffmann E, Wojciechowski D, et al. Defibrillator implantation early after myocardial infarction. N Engl J Med. 2009;361:1427–36.

    Article  PubMed  CAS  Google Scholar 

  35. Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The cardiac arrhythmia suppression trial. N Engl J Med. 1991;324:781–8.

    Article  PubMed  CAS  Google Scholar 

  36. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. The Cardiac Arrhythmia Suppression Trial II investigators. N Engl J Med. 1992;327:227–33.

    Google Scholar 

  37. Mason JW. A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias. Electrophysiologic study versus electrocardiographic monitoring investigators. N Engl J Med. 1993;329:445–51.

    Article  PubMed  CAS  Google Scholar 

  38. Cardiac Arrest in Seattle: Conventional Versus Amiodarone Drug Evaluation (the CASCADE study). Am J Cardiol. 1991;67:578–84.

    Google Scholar 

  39. Krishnan SC, Antzelevitch C. Flecainide-induced arrhythmia in canine ventricular epicardium. Phase 2 reentry? Circulation. 1993;87:562–72.

    Article  PubMed  CAS  Google Scholar 

  40. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter automatic defibrillator implantation trial investigators. N Engl J Med. 1996;335:1933–40.

    Article  PubMed  CAS  Google Scholar 

  41. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877–83.

    Article  PubMed  Google Scholar 

  42. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225–37.

    Article  PubMed  CAS  Google Scholar 

  43. Brembilla-Perrot B, Suty-Selton C, Alla F, Beurrier D, Houriez P, Claudon O, et al. Risk factors for ­cardiac mortality in cases of syncope with previous history of myocardial infarction. Arch Mal Coeur Vaiss. 2003;96:1181–6.

    PubMed  CAS  Google Scholar 

  44. Brembilla-Perrot B, Suty-Selton C, Houriez P, Claudon O, Beurrier D, Terrier de la Chaise A. Value of non-invasive and invasive studies in patients with bundle branch block, syncope and history of myocardial infarction. Europace. 2001;3:187–94.

    Article  PubMed  CAS  Google Scholar 

  45. Gohlke-Barwolf C, Peters K, Petersen J, Samek L, Eschenbruch E, Birnbaum D, et al. Influence of aortic valve replacement on sudden death in patients with pure aortic stenosis. Eur Heart J. 1988;9(Suppl E):139–41.

    Article  PubMed  Google Scholar 

  46. Martinez-Rubio A, Schwammenthal Y, Schwammenthal E, Block M, Reinhardt L, Garcia-Alberola A, et al. Patients with valvular heart disease presenting with sustained ventricular tachyarrhythmias or syncope: results of programmed ventricular stimulation and long-term follow-up. Circulation. 1997;96:500–8.

    Article  PubMed  CAS  Google Scholar 

  47. Gatzoulis MA, Balaji S, Webber SA, Siu SC, Hokanson JS, Poile C, et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet. 2000;356:975–81.

    Article  PubMed  CAS  Google Scholar 

  48. Khairy P, Landzberg MJ, Gatzoulis MA, Lucron H, Lambert J, Marcon F, et al. Value of programmed ventricular stimulation after tetralogy of Fallot repair: a multicenter study. Circulation. 2004;109:1994–2000.

    Article  PubMed  Google Scholar 

  49. Khairy P. Programmed ventricular stimulation for risk stratification in patients with tetralogy of Fallot: a Bayesian perspective. Nat Clin Pract Cardiovasc Med. 2007;4:292–3.

    Article  PubMed  Google Scholar 

  50. Alexander ME, Walsh EP, Saul JP, Epstein MR, Triedman JK. Value of programmed ventricular stimulation in patients with congenital heart disease. J Cardiovasc Electrophysiol. 1999;10:1033–44.

    Article  PubMed  CAS  Google Scholar 

  51. Hsia HH, Callans DJ, Marchlinski FE. Characterization of endocardial electrophysiological substrate in patients with nonischemic cardiomyopathy and monomorphic ventricular tachycardia. Circulation. 2003;108:704–10.

    Article  PubMed  Google Scholar 

  52. Hsia HH, Marchlinski FE. Characterization of the electroanatomic substrate for monomorphic ventricular tachycardia in patients with nonischemic cardiomyopathy. Pacing Clin Electrophysiol. 2002;25:1114–27.

    Article  PubMed  Google Scholar 

  53. Soejima K, Stevenson WG, Sapp JL, Selwyn AP, Couper G, Epstein LM. Endocardial and epicardial radiofrequency ablation of ventricular tachycardia associated with dilated cardiomyopathy: the importance of low-voltage scars. J Am Coll Cardiol. 2004;43:1834–42.

    Article  PubMed  Google Scholar 

  54. Caceres J, Jazayeri M, McKinnie J, Avitall B, Denker ST, Tchou P, et al. Sustained bundle branch reentry as a mechanism of clinical tachycardia. Circulation. 1989;79:256–70.

    Article  PubMed  CAS  Google Scholar 

  55. Becker R, Haass M, Ick D, Krueger C, Bauer A, Senges-Becker JC, et al. Role of nonsustained ventricular tachycardia and programmed ventricular stimulation for risk stratification in patients with idiopathic dilated cardiomyopathy. Basic Res Cardiol. 2003;98:259–66.

    PubMed  Google Scholar 

  56. Gonska BD, Bethge KP, Kreuzer H. Programmed ventricular stimulation in coronary artery disease and dilated cardiomyopathy: influence of the underlying heart disease on the results of electrophysiologic testing. Clin Cardiol. 1987;10:294–304.

    Article  PubMed  CAS  Google Scholar 

  57. Turitto G, Ahuja RK, Caref EB, el Sherif N. Risk stratification for arrhythmic events in patients with nonischemic dilated cardiomyopathy and nonsustained ventricular tachycardia: role of programmed ventricular stimulation and the signal-averaged electrocardiogram. J Am Coll Cardiol. 1994;24:1523–8.

    Article  PubMed  CAS  Google Scholar 

  58. Brilakis ES, Shen WK, Hammill SC, Hodge DO, Rea RF, Lexvold NY, et al. Role of programmed ventricular stimulation and implantable cardioverter defibrillators in patients with idiopathic dilated cardiomyopathy and syncope. Pacing Clin Electrophysiol. 2001;24:1623–30.

    Article  PubMed  CAS  Google Scholar 

  59. Grimm W, Hoffmann J, Menz V, Luck K, Maisch B. Programmed ventricular stimulation for arrhythmia risk prediction in patients with idiopathic dilated cardiomyopathy and nonsustained ventricular tachycardia. J Am Coll Cardiol. 1998;32:739–45.

    Article  PubMed  CAS  Google Scholar 

  60. Milner PG, DiMarco JP, Lerman BB. Electrophysiological evaluation of sustained ventricular tachyarrhythmias in idiopathic dilated cardiomyopathy. Pacing Clin Electrophysiol. 1988;11:562–8.

    Article  PubMed  CAS  Google Scholar 

  61. Poll DS, Marchlinski FE, Buxton AE, Doherty JU, Waxman HL, Josephson ME. Sustained ventricular tachycardia in patients with idiopathic dilated cardiomyopathy: electrophysiologic testing and lack of response to antiarrhythmic drug therapy. Circulation. 1984;70:451–6.

    Article  PubMed  CAS  Google Scholar 

  62. Turitto G, Ahuja RK, Bekheit S, Caref EB, Ibrahim B, el Sherif N. Incidence and prediction of induced ventricular tachyarrhythmias in idiopathic dilated cardiomyopathy. Am J Cardiol. 1994;73:770–3.

    Article  PubMed  CAS  Google Scholar 

  63. Rolf S, Haverkamp W, Borggrefe M, Breithardt G, Bocker D. Induction of ventricular fibrillation rather than ventricular tachycardia predicts tachyarrhythmia recurrences in patients with ­idiopathic dilated cardiomyopathy and implantable cardioverter defibrillator for secondary ­prophylaxis. Europace. 2009;11:289–96.

    Article  PubMed  Google Scholar 

  64. Pogwizd SM. Nonreentrant mechanisms underlying spontaneous ventricular arrhythmias in a model of nonischemic heart failure in rabbits. Circulation. 1995;92:1034–48.

    Article  PubMed  CAS  Google Scholar 

  65. Pogwizd SM, McKenzie JP, Cain ME. Mechanisms underlying spontaneous and induced ventricular arrhythmias in patients with idiopathic dilated cardiomyopathy. Circulation. 1998;98:2404–14.

    Article  PubMed  CAS  Google Scholar 

  66. Elliott PM, Poloniecki J, Dickie S, Sharma S, Monserrat L, Varnava A, et al. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol. 2000;36:2212–8.

    Article  PubMed  CAS  Google Scholar 

  67. Maron BJ, Shen WK, Link MS, Epstein AE, Almquist AK, Daubert JP, et al. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med. 2000;342:365–73.

    Article  PubMed  CAS  Google Scholar 

  68. Fananapazir L, Tracy CM, Leon MB, Winkler JB, Cannon III RO, Bonow RO, et al. Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy. A consecutive analysis in 155 patients. Circulation. 1989;80:1259–68.

    Article  PubMed  CAS  Google Scholar 

  69. Watson RM, Schwartz JL, Maron BJ, Tucker E, Rosing DR, Josephson ME. Inducible polymorphic ventricular tachycardia and ventricular fibrillation in a subgroup of patients with hypertrophic cardiomyopathy at high risk for sudden death. J Am Coll Cardiol. 1987;10:761–74.

    Article  PubMed  CAS  Google Scholar 

  70. Zhu DW, Sun H, Hill R, Roberts R. The value of electrophysiology study and prophylactic implantation of cardioverter defibrillator in patients with hypertrophic cardiomyopathy. Pacing Clin Electrophysiol. 1998;21:299–302.

    Article  PubMed  CAS  Google Scholar 

  71. Hedman A, Hartikainen J, Vanninen E, Laitinen T, Jaaskelainen P, Laakso M, et al. Inducibility of life-threatening ventricular arrhythmias is related to maximum left ventricular thickness and clinical markers of sudden cardiac death in patients with hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha-tropomyosin gene. J Mol Cell Cardiol. 2004;36:91–9.

    Article  PubMed  CAS  Google Scholar 

  72. Fananapazir L, Chang AC, Epstein SE, McAreavey D. Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiological findings. Circulation. 1992;86:730–40.

    Article  PubMed  CAS  Google Scholar 

  73. Behr ER, Elliott P, McKenna WJ. Role of invasive EP testing in the evaluation and management of hypertrophic cardiomyopathy. Card Electrophysiol Rev. 2002;6:482–6.

    Article  PubMed  Google Scholar 

  74. Yamashiro S, Kuniyoshi Y, Miyagi K, Uezu T, Arakaki K, Koja K. Two cases of ventricular tachycardia with congenital left ventricular malformation in an adult. Ann Thorac Cardiovasc Surg. 2004;10:42–6.

    PubMed  Google Scholar 

  75. Ellison KE, Friedman PL, Ganz LI, Stevenson WG. Entrainment mapping and radiofrequency catheter ablation of ventricular tachycardia in right ventricular dysplasia. J Am Coll Cardiol. 1998;32:724–8.

    Article  PubMed  CAS  Google Scholar 

  76. Marchlinski FE, Zado E, Dixit S, Gerstenfeld E, Callans DJ, Hsia H, et al. Electroanatomic substrate and outcome of catheter ablative therapy for ventricular tachycardia in setting of right ventricular cardiomyopathy. Circulation. 2004;110:2293–8.

    Article  PubMed  Google Scholar 

  77. Pezawas T, Stix G, Kastner J, Schneider B, Wolzt M, Schmidinger H. Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up. Int J Cardiol. 2006;107:360–8.

    Article  PubMed  Google Scholar 

  78. Corrado D, Leoni L, Link MS, Della BP, Gaita F, Curnis A, et al. Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation. 2003;108:3084–91.

    Article  PubMed  Google Scholar 

  79. Corrado D, Calkins H, Link MS, Leoni L, Favale S, Bevilacqua M, et al. Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia. Circulation. 2010;122:1144–52.

    Article  PubMed  Google Scholar 

  80. Sarabanda AV, Sosa E, Simoes MV, Figueiredo GL, Pintya AO, Marin-Neto JA. Ventricular tachycardia in Chagas’ disease: a comparison of clinical, angiographic, electrophysiologic and myocardial perfusion disturbances between patients presenting with either sustained or nonsustained forms. Int J Cardiol. 2005;102:9–19.

    Article  PubMed  Google Scholar 

  81. Silva RM, Tavora MZ, Gondim FA, Metha N, Hara VM, Paola AA. Predictive value of clinical and electrophysiological variables in patients with chronic chagasic cardiomyopathy and nonsustained ventricular tachycardia. Arq Bras Cardiol. 2000;75:33–47.

    Article  PubMed  CAS  Google Scholar 

  82. Grollier G, Galateau F, Scanu P, Commeau P, Voglimacci M, Bernard JP, et al. Cardiac sarcoidosis responsible for localized left ventricular ectasia and refractory ventricular tachycardia. Anatomoclinical study. Arch Mal Coeur Vaiss. 1990;83:561–4.

    PubMed  CAS  Google Scholar 

  83. Jain A, Starek PJ, Delany DL. Ventricular tachycardia and ventricular aneurysm due to unrecognized sarcoidosis. Clin Cardiol. 1990;13:738–40.

    Article  PubMed  CAS  Google Scholar 

  84. Toda G, Iliev II, Kawahara F, Hayano M, Yano K. Left ventricular aneurysm without coronary artery disease, incidence and clinical features: clinical analysis of 11 cases. Intern Med. 2000;39:531–6.

    Article  PubMed  CAS  Google Scholar 

  85. Aizer A, Stern EH, Gomes JA, Teirstein AS, Eckart RE, Mehta D. Usefulness of programmed ventricular stimulation in predicting future arrhythmic events in patients with cardiac sarcoidosis. Am J Cardiol. 2005;96:276–82.

    Article  PubMed  Google Scholar 

  86. Furushima H, Chinushi M, Sugiura H, Kasai H, Washizuka T, Aizawa Y. Ventricular tachyarrhythmia associated with cardiac sarcoidosis: its mechanisms and outcome. Clin Cardiol. 2004;27:217–22.

    Article  PubMed  Google Scholar 

  87. Chinushi M, Mezaki T, Aoki Y, Nakagawa I, Washizuka T, Aizawa Y. Demonstration of transient entrainment in monomorphic sustained ventricular tachycardia associated with cardiac sarcoidosis. Jpn Circ J. 2000;64:635–7.

    Article  PubMed  CAS  Google Scholar 

  88. Noda T, Suyama K, Shimizu W, Satomi K, Otomo K, Okamura H, et al. Ventricular tachycardia with figure eight pattern originating from the right ventricle in a patient with cardiac sarcoidosis. Pacing Clin Electrophysiol. 2004;27:561–2.

    Article  PubMed  Google Scholar 

  89. Mezaki T, Chinushi M, Washizuka T, Furushima H, Chinushi Y, Ebe K, et al. Discrepancy between inducibility of ventricular tachycardia and activity of cardiac sarcoidosis. Requirement of defibrillator implantation for the inactive stage of cardiac sarcoidosis. Intern Med. 2001;40:731–5.

    Article  PubMed  CAS  Google Scholar 

  90. Mehta D, Mori N, Goldbarg SH, Lubitz S, Wisnivesky JP, Teirstein A. Primary prevention of sudden cardiac death in silent cardiac sarcoidosis: role of programmed ventricular stimulation. Circ Arrhythm Electrophysiol. 2011;4:43–8.

    Article  PubMed  Google Scholar 

  91. Bhandari AK, Shapiro WA, Morady F, Shen EN, Mason J, Scheinman MM. Electrophysiologic testing in patients with the long QT syndrome. Circulation. 1985;71:63–71.

    Article  PubMed  CAS  Google Scholar 

  92. Gasparini M, Priori SG, Mantica M, Coltorti F, Napolitano C, Galimberti P, et al. Programmed electrical stimulation in Brugada syndrome: how reproducible are the results? J Cardiovasc Electrophysiol. 2002;13:880–7.

    Article  PubMed  Google Scholar 

  93. Brugada J, Brugada R, Brugada P. Determinants of sudden cardiac death in individuals with the electrocardiographic pattern of Brugada syndrome and no previous cardiac arrest. Circulation. 2003;108:3092–6.

    Article  PubMed  Google Scholar 

  94. Brugada P, Brugada R, Mont L, Rivero M, Geelen P, Brugada J. Natural history of Brugada syndrome: the prognostic value of programmed electrical stimulation of the heart. J Cardiovasc Electrophysiol. 2003;14:455–7.

    Article  PubMed  Google Scholar 

  95. Brugada P, Geelen P, Brugada R, Mont L, Brugada J. Prognostic value of electrophysiologic investigations in Brugada syndrome. J Cardiovasc Electrophysiol. 2001;12:1004–7.

    Article  PubMed  CAS  Google Scholar 

  96. Priori SG, Napolitano C, Gasparini M, Pappone C, Della BP, Giordano U, et al. Natural history of Brugada syndrome: insights for risk stratification and management. Circulation. 2002;105:1342–7.

    Article  PubMed  Google Scholar 

  97. Eckardt L, Kirchhof P, Schulze-Bahr E, Rolf S, Ribbing M, Loh P, et al. Electrophysiologic ­investigation in Brugada syndrome; yield of ­programmed ventricular stimulation at two ­ventricular sites with up to three premature beats. Eur Heart J. 2002;23:1394–401.

    Article  PubMed  CAS  Google Scholar 

  98. Kanda M, Shimizu W, Matsuo K, Nagaya N, Taguchi A, Suyama K, et al. Electrophysiologic characteristics and implications of induced ventricular fibrillation in symptomatic patients with Brugada syndrome. J Am Coll Cardiol. 2002;39:1799–805.

    Article  PubMed  Google Scholar 

  99. Eckardt L, Probst V, Smits JP, Bahr ES, Wolpert C, Schimpf R, et al. Long-term prognosis of individuals with right precordial ST-segment-elevation Brugada syndrome. Circulation. 2005;111:257–63.

    Article  PubMed  Google Scholar 

  100. Paul M, Gerss J, Schulze-Bahr E, Wichter T, Vahlhaus C, Wilde AA, et al. Role of programmed ventricular stimulation in patients with Brugada syndrome: a meta-analysis of worldwide published data. Eur Heart J. 2007;28:2126–33.

    Article  PubMed  Google Scholar 

  101. Singh JP, Hall WJ, McNitt S, Wang H, Daubert JP, Zareba W, et al. Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II). J Am Coll Cardiol. 2005;46:1712–20.

    Article  PubMed  Google Scholar 

  102. Buxton AE, Lee KL, Hafley GE, Wyse DG, Fisher JD, Lehmann MH, et al. Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease: an analysis of patients enrolled in the multicenter unsustained tachycardia trial. Circulation. 2002;106:2466–72.

    Article  PubMed  CAS  Google Scholar 

  103. Chen SA, Chiang CE, Tai CT, Cheng CC, Chiou CW, Lee SH, et al. Complications of diagnostic electrophysiologic studies and radiofrequency catheter ablation in patients with tachyarrhythmias: an eight-year survey of 3,966 consecutive procedures in a tertiary referral center. Am J Cardiol. 1996;77:41–6.

    Article  PubMed  CAS  Google Scholar 

  104. Voss F, Lu J, Schreiner KD, Bauer A, Becker R, Kubler W, et al. Evaluation of syncope in geriatric patients: normal values, complications and outcome of invasive electrophysiological study. Z Kardiol. 2000;89:1026–31.

    Article  PubMed  CAS  Google Scholar 

  105. Wagshal AB, Schuger CD, Habbal B, Mittleman RS, Huang SK. Invasive electrophysiologic evaluation in octogenarians: is age a limiting factor? Am Heart J. 1993;126:1142–6.

    Article  PubMed  CAS  Google Scholar 

  106. Timmermans C, Smeets JL, Rodriguez LM, Vrouchos G, van den Dool A, Wellens HJ. Aborted sudden death in the Wolff-Parkinson-White syndrome. Am J Cardiol. 1995;76:492–4.

    Article  PubMed  CAS  Google Scholar 

  107. Munger TM, Packer DL, Hammill SC, Feldman BJ, Bailey KR, Ballard DJ, et al. A population study of the natural history of Wolff-Parkinson-White syndrome in Olmsted County, Minnesota, 1953–1989. Circulation. 1993;87:866–73.

    Article  PubMed  CAS  Google Scholar 

  108. Goudevenos JA, Katsouras CS, Graekas G, Argiri O, Giogiakas V, Sideris DA. Ventricular pre-excitation in the general population: a study on the mode of presentation and clinical course. Heart. 2000;83:29–34.

    Article  PubMed  CAS  Google Scholar 

  109. Attoyan C, Haissaguerre M, Dartigues JF, Le Metayer P, Warin JF, Clementy J. Ventricular fibrillation in Wolff-Parkinson-White syndrome. Predictive factors. Arch Mal Coeur Vaiss. 1994;87:889–97.

    PubMed  CAS  Google Scholar 

  110. Fananapazir L, Packer DL, German LD, Greer GS, Gallagher JJ, Pressley JC, et al. Procainamide infusion test: inability to identify patients with Wolff-Parkinson-White syndrome who are potentially at risk of sudden death. Circulation. 1988;77:1291–6.

    Article  PubMed  CAS  Google Scholar 

  111. Klein GJ, Bashore TM, Sellers TD, Pritchett EL, Smith WM, Gallagher JJ. Ventricular fibrillation in the Wolff-Parkinson-White syndrome. N Engl J Med. 1979;301:1080–5.

    Article  PubMed  CAS  Google Scholar 

  112. Boahene KA, Klein GJ, Sharma AD, Yee R, Fujimura O. Value of a revised procainamide test in the Wolff-Parkinson-White syndrome. Am J Cardiol. 1990;65:195–200.

    Article  PubMed  CAS  Google Scholar 

  113. Gaita F, Giustetto C, Riccardi R, Mangiardi L, Brusca A. Stress and pharmacologic tests as methods to identify patients with Wolff-Parkinson-White syndrome at risk of sudden death. Am J Cardiol. 1989;64:487–90.

    Article  PubMed  CAS  Google Scholar 

  114. Wellens HJ, Braat S, Brugada P, Gorgels AP, Bar FW. Use of procainamide in patients with the Wolff-Parkinson-White syndrome to disclose a short refractory period of the accessory pathway. Am J Cardiol. 1982;50:1087–9.

    Article  PubMed  CAS  Google Scholar 

  115. Medeiros A, Iturralde P, Guevara M, Mendoza C, Colin L. Sudden death in intermittent Wolff Parkinson White syndrome. Arch Cardiol Mex. 2001;71:59–65.

    PubMed  CAS  Google Scholar 

  116. Scheinman MM, Weiss A, Kunkel F. His bundle recordings in patients with bundle branch block and transient neurologic symptoms. Circulation. 1973;48:322–30.

    Article  PubMed  CAS  Google Scholar 

  117. Scheinman MM, Peters RW, Modin G, Brennan M, Mies C, O’Young J. Prognostic value of infranodal conduction time in patients with chronic bundle branch block. Circulation. 1977;56:240–4.

    Article  PubMed  CAS  Google Scholar 

  118. McAnulty JH, Rahimtoola SH, Murphy E, DeMots H, Ritzmann L, Kanarek PE, et al. Natural history of “high-risk” bundle-branch block: final report of a prospective study. N Engl J Med. 1982;307:137–43.

    Article  PubMed  CAS  Google Scholar 

  119. Dhingra RC, Palileo E, Strasberg B, Swiryn S, Bauernfeind RA, Wyndham CR, et al. Significance of the HV interval in 517 patients with chronic bifascicular block. Circulation. 1981;64:1265–71.

    Article  PubMed  CAS  Google Scholar 

  120. Dhingra RC, Wyndham C, Bauernfeind R, Swiryn S, Deedwania PC, Smith T, et al. Significance of block distal to the his bundle induced by atrial pacing in patients with chronic bifascicular block. Circulation. 1979;60:1455–64.

    Article  PubMed  CAS  Google Scholar 

  121. Petrac D, Radic B, Birtic K, Gjurovic J. Prospective evaluation of infrahisal second-degree AV block induced by atrial pacing in the presence of chronic bundle branch block and syncope. Pacing Clin Electrophysiol. 1996;19:784–92.

    Article  PubMed  CAS  Google Scholar 

  122. Twidale N, Heddle WF, Ayres BF, Tonkin AM. Clinical implications of electrophysiology study findings in patients with chronic bifascicular block and syncope. Aust N Z J Med. 1988;18:841–7.

    Article  PubMed  CAS  Google Scholar 

  123. Twidale N, Heddle WF, Tonkin AM. Procainamide administration during electrophysiology study – utility as a provocative test for intermittent atrioventricular block. Pacing Clin Electrophysiol. 1988;11:1388–97.

    PubMed  CAS  Google Scholar 

  124. Girard SE, Munger TM, Hammill SC, Shen WK. The effect of intravenous procainamide on the HV interval at electrophysiologic study. J Interv Card Electrophysiol. 1999;3:129–37.

    Article  PubMed  CAS  Google Scholar 

  125. Brignole M, Menozzi C, Moya A, Garcia-Civera R, Mont L, Alvarez M, et al. Mechanism of syncope in patients with bundle branch block and ­negative electrophysiological test. Circulation. 2001;104:2045–50.

    Article  PubMed  CAS  Google Scholar 

  126. Lazarus A, Varin J, Babuty D, Anselme F, Coste J, Duboc D. Long-term follow-up of arrhythmias in patients with myotonic dystrophy treated by pacing: a multicenter diagnostic pacemaker study. J Am Coll Cardiol. 2002;40:1645–52.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine and Clinical Cardiac Electrophysiology, Cardiovascular Institute, University of Pittsburgh, 200 Lothrop Street, Scaife 535, Pittsburgh, PA, 15213, USA

    Jan Němec MD, FACC

  2. Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic College of Medicine, Mayo Clinic Arizona, Phoenix, AZ, USA

    Win-Kuang Shen MD

Authors
  1. Jan Němec MD, FACC
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Win-Kuang Shen MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jan Němec MD, FACC .

Editor information

Editors and Affiliations

  1. , Department of Internal Medicine, UMDNJ-RWJ Medical School, Robert Wood Johnson Pl. 1, New Brunswick, 08903-0019, New Jersey, USA

    Ihor Gussak

  2. , Gordon K. Moe Scholar, Masonic Medical Research Laboratory, Bleecker Street, Utica, 13501-1787, New York, USA

    Charles Antzelevitch

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag London

About this chapter

Cite this chapter

Němec, J., Shen, WK. (2013). Invasive Electrophysiologic Testing: Role in Sudden Death Prediction. In: Gussak, I., Antzelevitch, C. (eds) Electrical Diseases of the Heart. Springer, London. https://doi.org/10.1007/978-1-4471-4978-1_17

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-4978-1_17

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-4977-4

  • Online ISBN: 978-1-4471-4978-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation